Ameritas Investment Partners’s HOOKIPA Pharma HOOK Stock Holding History

Ameritas Investment Partners’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-86	Closed	-$2K	–	3139
2022 Q1	$2K	Hold	86	–	–	﹤0.01%	3046
2021 Q4	$2K	Hold	86	–	–	﹤0.01%	3093
2021 Q3	$5K	Hold	86	–	–	﹤0.01%	3033
2021 Q2	$8K	Hold	86	–	–	﹤0.01%	2958
2021 Q1	$12K	Hold	86	–	–	﹤0.01%	2775
2020 Q4	$10K	Hold	86	–	–	﹤0.01%	2784
2020 Q3	$8K	Hold	86	–	–	﹤0.01%	2809
2020 Q2	$10K	Hold	86	–	–	﹤0.01%	2716
2020 Q1	$7K	Buy	86 +68	+378%	+$7.45K	﹤0.01%	2682
2019 Q4	$2K	Hold	18	–	–	﹤0.01%	2970
2019 Q3	$1K	Hold	18	–	–	﹤0.01%	3046
2019 Q2	$1K	Buy	+18	New	+$1.91K	﹤0.01%	3033

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's HOOK Position: Q2 2022 in Review

Ameritas Investment Partners sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 86 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in HOOK in Q2 2019 and held it in 12 quarters. The position peaked at $12K in Q1 2021. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

Ameritas Investment Partners reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 86 HOOKIPA Pharma shares in Q2 2022, an estimated $2K.
Ameritas Investment Partners first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 12 quarters.
Ameritas Investment Partners's HOOKIPA Pharma position peaked at $12K in Q1 2021.
58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.